Cytotoxic effects of 6-hydroxydopamine, merocyanine-540 and related compounds on human neuroblastoma and hematopoietic stem cells

Free Radical Research Communications
G BrucheltD Niethammer

Abstract

6-Hydroxydopamine(6-OHDA) and Merocyanine-540(MC-540) have been used clinically for purging of neuroblastoma cells prior to autologous bone marrow transplantation. Both substances were found to be more toxic against neuroblastoma cells than against hematopoietic stem cells. The more pronounced cytotoxic effects of 6-OHDA against neuroblastoma cells were not caused by its selective uptake; the rapid autooxidation at physiological pH leads to the formation of H2O2 already in the incubation medium. Cytotoxic effects were not detected in short-time test systems (4 hour chromium-51 release assay) but only after longer incubation periods. In contrast, MC-540 proved to be toxic almost equally in short- and long-time test systems. 4-Hydroxynonenal(4-HNE) that may be formed in the plasma membrane subsequently to photoactivation of MC-540 was only slightly more toxic to neuroblastoma cells than to hematopoietic cells. Although the use of 6-OHDA and MC-540 in bone marrow purging has some limitations, the sensitivity of neuroblastoma cells against reactive oxygen compounds may be exploited more generally for therapy of this tumor.

References

Jul 29, 1977·Science·A W Hamburger, S E Salmon
Jun 1, 1976·Scandinavian Journal of Immunology·A Bøyum
Sep 1, 1988·The Journal of Clinical Investigation·I SchraufstätterC G Cochrane
Jul 16, 1985·Biochemical and Biophysical Research Communications·G BrucheltD Niethammer
May 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·B KalyanaramanA W Girotti
Jul 15, 1988·Cancer·C E KleinL M Glode
Jan 1, 1985·Journal of Free Radicals in Biology & Medicine·W J BrattinR O Recknagel
Feb 1, 1985·Seminars in Liver Disease·R SalataG S Levey
Jun 1, 1984·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C S AugustG J D'Angio
Dec 1, 1980·The American Journal of Medicine·J BlattD G Poplack

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.